COMMUNIQUÉS West-GlobeNewswire

PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES

16/04/2025 - 15:30

MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and [...]

Olon Receives 2025 CMO Excellence in Green Chemistry Award

16/04/2025 - 15:37

RODANO, Italy, April 16, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. is honored to announce its receipt of the esteemed 2025 CMO Excellence in Green Chemistry Award. This accolade, conferred by the ACS Green Chemistry [...]

Ivy En Rose MedSpa and The Junior League of San Francisco Announce New Date For Their Partnered Event, To Be Held on May 20, 2025

16/04/2025 - 16:00

SAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- Ivy En Rose , San Francisco’s premier elite MedSpa, is proud to announce an exciting partnership with the Junior League of San Francisco for an exclusive community event [...]

First Steroid Cycle: Beginner’s Guide to Bulking & Cutting + (Before And After Result ) - 2025 - By CrazyBulk in USA

16/04/2025 - 16:55

New York City, April 16, 2025 (GLOBE NEWSWIRE) -- As long as a beginner wants to achieve huge increases in muscle mass size and bulk, starting a cycle of steroids can be very effective. This article provides a [...]

Sustanon 250: Sustanon Testosterone Cycle Results, Buy Top Sustanon 250 Injection Alternative For Bodybuilding By CrazyBulk

16/04/2025 - 12:32

Sustanon 250 Injections and Sustanon Testosterone are testosterone boosters. According to the maker, they are safe to use and employ natural ingredients to boost overall health and wellness. Albany, New York, April 16, [...]

AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan

16/04/2025 - 13:00

LONDON and PHOENIX, April 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced [...]

Spectral Medical Completes Tigris Trial Enrollment

16/04/2025 - 13:00

157 patients enrolled Topline results expected to be released in August 2025 Company to host Corporate Update Call on May 15, 2025 TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “ [...]

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

16/04/2025 - 13:00

CHATHAM, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of [...]

Cannara Biotech Inc. annoncera ses résultats financiers pour le deuxième trimestre de l'exercice 2025 le 28 avril 2025

16/04/2025 - 13:00

MONTRÉAL, 16 avr. 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara » , « la Société » , « nous » ou « notre ») ( TSXV : LOVE ) ( OTCQB : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis [...]

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

16/04/2025 - 13:00

MONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]

INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology

16/04/2025 - 13:00

Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announced [...]

Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer

16/04/2025 - 13:00

Dr. Taub’s pioneering research in academia and industry led to the first FDA-approved therapy for patients with MASH CONSHOHOCKEN, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a [...]

Tilray Brands Ranks #4 on the Brewers Association List of Top Producing Craft Brewers in the United States

16/04/2025 - 13:00

Tilray Beverages Climbs to #4! Cheers to Ranking Among the Top Craft Brewers in the U.S.! NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Tilray Beverages, a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is [...]

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

16/04/2025 - 13:00

WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]

Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis

16/04/2025 - 13:00

Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2 2025 CLN-978 is also being studied in the U.S., Europe, and Australia for [...]

Oxford Scientists Reveal Sunlight-Powered Anti-Cancer Breakthrough

16/04/2025 - 13:14

OXFORD, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Dr. Daniel Chen, at the University of Oxford and Chief Scientist at biotech startup Oxperial BioHealth , revealed their major breakthrough in cancer prevention— [...]

Avicanna Announces Revocation of Management Cease Trade Order

16/04/2025 - 13:30

TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization [...]

LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation

16/04/2025 - 13:30

Exemption from the $5.1 million repayment obligation strengthens LAVA’s balance sheet Underscores focus on cost curtailment and strategic option evaluation UTRECHT, The Netherlands and PHILADELPHIA, April 16, 2025 ( [...]

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

16/04/2025 - 13:30

Median overall survival of 17.3 months in Bria-IMT™ treated patients with hormone receptor positive (HR+) metastatic breast cancer markedly exceeds historical data of 14.4 months in TRODELVY ® (sacituzumab govitecan- [...]